Patents by Inventor Nancy G. Mayne

Nancy G. Mayne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human glutamate receptor proteins and associated DNA compounds
    Patent number: 6312945
    Abstract: The present invention provides a human glutamate receptor and related DNA compounds useful not only in assays for potential pharmaceuticals but also in methods for molecular biology techniques.
    Type: Grant
    Filed: March 7, 1995
    Date of Patent: November 6, 2001
    Assignee: Eli Lilly and Company
    Inventors: J. Paul Burnett, Nancy G. Mayne, Robert L. Sharp, Yvonne M. Snyder
  • Human glutamate receptor and related DNA compounds
    Patent number: 6313279
    Abstract: The present invention provides a human glutamate receptor and related DNA compounds useful not only in assays for potential pharmaceuticals but also in methods for molecular biology techniques.
    Type: Grant
    Filed: December 22, 1993
    Date of Patent: November 6, 2001
    Assignee: Eli Lilly and Company
    Inventors: J. Paul Burnett, Nancy G. Mayne, Robert L. Sharp, Yvonne M. Snyder
  • Human metabotropic glutamate receptor and related DNA compounds
    Patent number: 6303751
    Abstract: This invention provides a human glutamate receptor and functional equivalents thereof, and nucleic acids compounds which encode the receptor. The invention also provides assays, probes and primers, and other molecular biology techniques which utilize the compounds disclosed.
    Type: Grant
    Filed: October 3, 1995
    Date of Patent: October 16, 2001
    Assignee: Eli Lilly and Company
    Inventors: J. Paul Burnett, Nancy G. Mayne, Robert L. Sharp, Yvonne M. Snyder
  • Cloning vectors for expression of exogenous protein
    Patent number: 4745069
    Abstract: A recombinant DNA cloning vector useful for expressing exogenous protein is described, which comprises(a) a DNA segment containing a functional origin of replication;(b) one or more DNA segments, each of which conveys to a transformable host cell a property useful for selection when said vector is transformed into said host cell; and(c) a DNA segment comprising a sequence that defines, in tandem,(1) the promoter of a lipoprotein expression control sequence,(2) the 5' untranslated region of a lipoprotein expression control sequence and(3) a translation start codon followed, without interposition of a portion or all of a nucleotide sequence coding for endogenous protein, by a nucleotide sequence coding for an enterokinase cleavage site to which is joined, without interruption, a nucleotide sequence coding for an exogenous protein.
    Type: Grant
    Filed: March 6, 1984
    Date of Patent: May 17, 1988
    Assignee: Eli Lilly and Company
    Inventors: Nancy G. Mayne, J. Paul Burnett, Ramamoorthy Belegaje, Hansen M. Hsiung